Posttransplant Lymphoproliferative Disease after Lung Transplantation
Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral host immunity and permits Epstein-Barr viral (EBV) replication and transformation of B cells. Mechanistically, EBV survives due to latency, escape from cytotoxi...
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Hindawi Limited
2013-01-01
|
| Serie: | Clinical and Developmental Immunology |
| Länkar: | http://dx.doi.org/10.1155/2013/430209 |